These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30773402)

  • 1. SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
    Durous L; Julien T; Padey B; Traversier A; Rosa-Calatrava M; Blum LJ; Marquette CA; Petiot E
    Vaccine; 2019 Mar; 37(12):1614-1621. PubMed ID: 30773402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-independent surface plasmon resonance assays for influenza vaccine quality control.
    Serafin B; Kamen A; de Crescenzo G; Henry O
    Appl Microbiol Biotechnol; 2024 Apr; 108(1):307. PubMed ID: 38656587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S; Soto J; Vasudevan A; Schmeisser F; Alvarado-Facundo E; Wang W; Weiss CD; Weir JP
    PLoS One; 2017; 12(4):e0175733. PubMed ID: 28423025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
    Khurana S; King LR; Manischewitz J; Coyle EM; Golding H
    Vaccine; 2014 Apr; 32(19):2188-97. PubMed ID: 24613520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
    Chae W; Kim P; Kim H; Cheong YC; Kim YS; Kang SM; Seong BL
    Sci Rep; 2019 Dec; 9(1):19675. PubMed ID: 31873147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC
    Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard.
    Takahashi H; Fujimoto T; Horikoshi F; Uotani T; Okutani M; Shimasaki N; Hamamoto I; Odagiri T; Nobusawa E
    Biologicals; 2020 Nov; 68():32-39. PubMed ID: 33023810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VaxArray assessment of influenza split vaccine potency and stability.
    Kuck LR; Saye S; Loob S; Roth-Eichhorn S; Byrne-Nash R; Rowlen KL
    Vaccine; 2017 Apr; 35(15):1918-1925. PubMed ID: 28262335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y; Han L; Palladino G; Ferrari A; Xie Y; Carfi A; Dormitzer PR; Settembre EC
    Vaccine; 2015 Oct; 33(41):5342-5349. PubMed ID: 26348403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay.
    Lorbetskie B; Cunningham AM; Lemieux M; Durno L; Farnsworth A; Wang J; Li C; Li X; Gilbert M; Sauvé S; Girard M
    Anal Chem; 2019 Jul; 91(14):8908-8917. PubMed ID: 31251585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
    Ekimov A; Arunachalam AB; Blake T; Bodle J; Couzens L; Dubey S; Eichelberger M; Engelhardt OG; Gubinelli F; Joshi M; Melnyk D; Palladino G; Rigsby P; Rockman S; Savina N; Smith E; Gilchrist SAN;
    Vaccine; 2023 Jul; 41(32):4639-4647. PubMed ID: 37344260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine.
    Li C; Xu K; Hashem A; Shao M; Liu S; Zou Y; Gao Q; Zhang Y; Yuan L; Xu M; Li X; Wang J
    Hum Vaccin Immunother; 2015; 11(6):1351-6. PubMed ID: 25970793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
    Schmeisser F; Vasudevan A; Soto J; Kumar A; Williams O; Weir JP
    Influenza Other Respir Viruses; 2014 Sep; 8(5):587-95. PubMed ID: 25087462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J; Vandenberg K; Laurie K; Barr IG; Zhang Y; Rockman S
    Front Immunol; 2023; 14():1147028. PubMed ID: 37033922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    An Y; Parsons LM; Jankowska E; Melnyk D; Joshi M; Cipollo JF
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies.
    Narayan K; Paduraru C; Blake T; Arunachalam AB
    Front Immunol; 2023; 14():1128683. PubMed ID: 37457687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y; Palladino G; Xie Y; Ferrari A; Ma X; Han L; Dormitzer PR; Settembre EC
    Vaccine; 2016 Jun; 34(29):3388-95. PubMed ID: 27154389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin.
    Eichelberger SL; Sultana I; Gao J; Getie-Kebtie M; Alterman M; Eichelberger MC
    Influenza Other Respir Viruses; 2013 Nov; 7(6):961-8. PubMed ID: 23496824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.